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SUMMARY
The modified New York criteria for the diagnosis of ankylosing spondylitis were evaluated and
compared to the older criteria in 151 patients, referred to hospital because of low back pain and who
had a positive clinical history screening test for ankylosing spondylitis and in 31 controls with non-
inflammatory back pain. Radiological examination of the sacro-iliac joints showed sacro-iliitis in 124
(82%) from the 151 with inflammatory back pain. In 110 (72%) of those patients a diagnosis of definite
ankylosing spondylitis according to the classical New York criteria could be made and they had a
prevalence of HLA-B27 of 84%. Application of the modified New York scheme increased the number
of patients meeting the criteria for definite ankylosing spondylitis to all 124 patients with sacro-iliitis,
and 82% of this group carried HLA-B27.
The classical New York criteria of 'limitation of the lumbar spine in three directions" and of
'limitation of chest expansion' appeared to reflect disease duration rather than help in the initial
diagnosis.
KEY WORDS: Clinical history screening test, Diagnostic criteria, HLA-B27, Ankylosing spondylitis.
THE distinction between back pain due to mechanical causes and that resulting from
inflammatory conditions such as ankylosing spondylitis (AS) can be difficult for the clinician
as well as the epidemiologist. A screening test for AS, based on the clinical history was
defined by Calin et al. (1). AS is characterized by insidious onset of back pain in a patient
younger than 40 years, persisting for at least three months, associated with morning stiffness
and improving with exercise and the test is considered to be positive if at least four of these
five items are answered affirmatively. More elaborate diagnostic criteria designed for
scientific studies and including the findings of physical and radiological examination were
framed in Rome (2) and revised in New York (NY) (3) (Tables I and II). Recently, modified
New York criteria (MNY) have been proposed (4) (Table I).The main points of divergence
from the previous NY are that the existing second clinical criterion concerning the symptom
of backache, which has a low specificity (4,5). isreplacedby a slight modification of the more
specific first Rome criterion about backache and that all the clinical criteria are given equal
weight. In addition the combined clinical and radiological findings are more liberally
interpreted.
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We have evaluated the prevalence of AS according to the Rome, the NY and the MNY
in 151 patients, referred to hospital because of low back pain, who had a positive clinical
history screening test for AS and in 31 controls with mechanical back pain. We also evaluated
the influence of the duration of the disease on the sensitivity of the diagnostic criteria.
PATIENTS AND METHODS
All patients who were referred between 1978 and 1982 to the rheumatological unit of
the De Wever Hospital with complaints of low back pain were screened for the presence of
inflammatory low back pain according to the aforementioned criteria (1). A total of 151
patients fulfilled these criteria and were considered to have inflammatory back pain. The
patients were referred by orthopaedic surgeons (32 patients), other specialists (20 patients)
and general practitioners (99 patients). Of the 99 patients referred by general practitioners,
59 had previously been seen by other specialists for the same complaints. As controls, a
consecutive group of 31 patients referred to the same department between 1979 and 1980
who did not meet the criteria for inflammatory back pain (1) were taken. At examination
none of the controls showed evidence of nerve root compression and 12 had lumbar disc
degeneration apparent radiologically. These 31 patients were therefore concluded to have
noninflammatory back pain. The mean age in the patient and control group was the same
(Table III) and the sex distribution was also comparable. The total group of patients with
inflammatory back pain but not the controls had an increased prevalence of HLA-B27
(72%).
The range of motion ot the lumbar spine was investigated in four directions (forward
flexion, lateral flexion to both sides and extension) and was expressed as either limited or
nonlimited on a purely subjective basis (5). Chest expansion was measured (in cm) at the
level of the fourth intercostal space. The clinical criteria for AS were evaluated without
knowledge of the radiology and the HLA status. HLA typing for the presence of B27 was
done in all subjects using the Histognost B27 test (Behringwerke AG).
After informed consent, radiological examination was performed and included an
antero-posterior pelvic view, and antero-posterior lateral and oblique views of the lumbar
spine. All radiographs were read 'blindly' by two radiologists (see Acknowledgements) and
one rheumatologist (GT). A sign, for example the presence of sacro-iliitis, was considered to
be present when at least two of the three observers noted it.
Sacro-iliac radiographs were graded according to the NY criteria (3) (Table II). Lumbar
spine radiographs were read for the presence of anterior spondylitis, squaring and syn-
desmophyte formation (Table II). Films of patients were mixed with the films of controls
before reading.
Statistics
Use was made of the chi square test with Yates' correction.
RESULTS
The characteristics of the patients and the controls are shown in Table III. The number
of patients meeting the obligatory number of criteria for the diagnosis of definite AS
according to the Rome, NY and MNY criteria is shown in Table IV. The MNY are, in the
presence of a positive clinical history screening test, obviously more sensitive than the Rome
or NY criteria (124 versus 115 and 110 cases of definite AS) and the additional cases also
show a high prevalence of HLA-B27. The prevalence of clinical Rome, NY and MNY
criteria in patients and controls with regard to the radiological grading of the sacro-iliac
joints is shown in Table V. The higher specificity of the first MNY criterion in contrast to the
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TABLE IV
NUMBER OF 151 PATIENTS WITH A POSITIVE SCREENING TEST FOR ANKYLOSING SPONDYLITIS MEETING
CRITERIA FOR DEFINITE DIAGNOSIS ACCORDING TO THE ROME, NEW YORK AND MODIFIED NEW YORK
SCHEMES
Diagnostic scheme
Number of
patients (%)
Number of HLA-B27
positive (%)
Rome: Overall 115 (76)
Radiological* + one clinical criterion 115 (76)
New York: Overall 110(73)
Grade* 3b+4b sacro-iliitis + one clinical criterion 102 (68)
Grade 2b or 3u sacro-iliitis + clinical criterion 1,
or + clinical criteria (2 + 3) 8 (5)
Modified New York: Overall 124 (82)
Grade 3b-4b sacro-iliitis + one clinical criterion 102 (68)
Grade 2b or 3u sacro-iliitis + one clinical criterion 22 (15)
94 (81)
94 (81)
92 (84)
87 (85)
5(63)
102 (82)
87 (85)
15 (68)
*2,3,4 = radiological grades; u = unilateral; b = bilateral.
TABLE V
THE PREVALENCE (%) OF ROME AND NEW YORK (NY) AND MODIFIED NY (MNY) CRITERIA IN PATIENTS
WITH INFLAMMATORY OR MECHANICAL BACK PAIN
Criterion Number
Rome New York
NY1/MNY2 NY3/MNY3
Inflammatory back pain
Sacro-iliitis:
Grade 3 or 4 bilaterally
Grade 2 bilaterally or
Grade 3 or 4 unilaterally
Grade 0 or 1*
Mechanical low back pain
151
102 44 94 38
22
27
31
23
41-
10-
95
74
74
0
0
3
0
0
0
36"
30c
19
0"
0=
3
'Unilateral grade 2 was not found in these groups.
Chi square test with Yates" correction, comparing: a with a, x2 = 6.00, p<0.02; b with b, x2 = 6.75,
p<0.01;c withe, x2 = 12.00, p<0.001; d with d, x2 = 10.56, p<0.001; e with e, x2 = 13.04, p<0.001.
second NY criterion in excluding cases of noninflammatory back pain is apparent. The 27
patients with inflammatory back pain without radiological sacro-iliitis had thoracic pain and
stiffness significantly more often than the 31 controls (Table V), and only six (22%) of these
27 patients were HLA-B27 positive. A comparison of radiological abnormalities with
limitation of spinal movement in four directions (NY 1, MNY 2) shows restricted motion in
more than two thirds of those with grade 3—4 bilateral sacro-iliitis but in only one third of
those with lesser degrees and this difference is statistically significant (Table V). Limited
chest expansion is only seen in the patients with more severe (grade 3—4) sacro-iliitis. The
prevalence of HLA-B27 is about the same in the patients with grade 3-4 bilateral and grade 2
bilateral or grade 3-4 unilateral sacro-iliitis, while the prevalence of HLA-B27 in the
patients without radiological sacro-iliitis does not differ from the controls (Tables III and
IV).
Limitation of motion in the lumbar spine and thoracic pain and stiffness increased
significantly in patients with more than five years duration of symptoms (Table VI) whereas
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TABLE VI
DURATION OF BACK PAIN RELATED TO SIGNS AND OTHER SYMPTOMS IN 124 PATIENTS WITH DEFINITE AS
ACCORDING TO THE MODIFIED NEW YORK CRITERIA
Duration of inflammatory low back pain
0-4 years 5-9 years ^ 10 years
(n = 62) (n = 30) (n = 32)
Number (%) Number (%) Number (%)
Limitation of motion of lumbar spine in 4 directions 28 (45)ab 23 (82)a 27 (87)b
Limitation of chest expansion =s2.5 cm 12 (24)c 10(36) 17 (55)c
Thoracic pain and stiffness 10 (16)d< 21 (71)" 19 (61)'
Chi square test with Yates' correction: (a) x2 = 6.898, p<0.009; (b) x2 = 11.803. p<0.001; (c) x2 =
9.756, p<0.002; (d) x2 = 23.906, p<0.001; (e) x2 = 16.18, p<0.001.
TABLE VII
RADIOLOGICAL INVOLVEMENT OF THE LUMBAR SPINE RELATED TO SIGNS AND SYMPTOMS IN 124 PATIENTS
WITH DEFINITE AS ACCORDING TO THE MODIFIED NEW YORK CRITERIA
Radiological lumbar spine involvement
Absent (n = 69) Present (n = 55)
Number (%) Number (%)
Limitation of motion of lumbar spine in 4 directions 29 (42)a 49 (89)d
Limitation of chest expansion 5*2.5 cm 9 (13)b 30 (55)b
Thoracic pain and stiffness 15 (22)c 35 (64)c
Chi square test with Yates' correction: (a) x2 = 27.07, p<0.001; (b) x2 = 22.56, p<0.001; (c) x2 = 20.62.
p<0.001.
limited chest expansion increased more gradually with time. Combined radiological involve-
ment of the sacro-iliac joints and the lumbar spine was associated with a significantly
increased prevalence of these three clinical criteria (Table VII).
HLA-B27 was present in 72% of the patients with inflammatory back pain and in 16% of
the controls. The prevalence of AS in the 108 HLA-B27 positive patients with inflammatory
back pain was 94%, but remained as high as 51% (22) of the 43 inflammatory back pain
patients negative for HLA-B27.
DISCUSSION
Diagnostic criteria have been framed for AS (2-5) and other rheumatic conditions to aid
clinicians and epidemiologists in different centres to ensure comparability between groups of
patients under study (4), but may aid clinical diagnosis although they have not been
prospectively tested in this setting. The criteria for AS, as stated in Rome (2) and New York
(3) have been criticized on grounds of sensitivity and specificity (5,6). Recently a revised set
of criteria (MNY) has been proposed (4). In the present study the modified criteria are
compared to the classical ones and all three sets of criteria for AS are tested in a group of
hospital out-patients with a positive clinical history screening test for AS (1).
The clinical history screening test for AS was initially reported to have a sensitivity of
95% in 42 HLA-B27 positive patients with definite AS according to the NY (1). A specificity
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of 95% was also found in 82 controls, including 21 HLA-B27 negative orthopaedic patients
although in all groups the screening test was applied to patients after the diagnosis was
known.
Our results demonstrate the value of the test as a screening procedure for AS in patients
with low back pain attending a rheumatology out-patient department as only 27 of the 151
patients without radiological sacro-iliitis (18%) did not fulfil the MNY for definite AS. A
bias in the referral pattern could have contributed to our finding of a high prevalence of AS
among inflammatory back pain patients as we had stressed the importance of the screening
test for AS at several postgraduate meetings. Therefore our data do not permit any estima-
tion of the prevalence of AS in all patients with chronic inflammatory back pain in the open
population. Nonetheless, a positive clinical history screening test for AS justifies a radiologi-
cal examination of the sacro-iliac joints and follow-up of the patients if radiological sacro-
iliitis cannot (yet) be demonstrated beyond doubt. As all diagnostic criteria rely to a great (2)
or absolute (3-4) extent on the presence of radiological sacro-iliitis to reach a diagnosis of
definite AS, the problem of early diagnosis, before the onset of radiological sacro-iliitis
remains to be solved.
In the MNY each of the clinical criteria has an equal weight and the diagnosis of definite
AS can be made in the presence of sacro-iliitis grade 2-4 bilaterally or grade 3—4 unilaterally
in the presence of only one clinical criterion. This leads to an increased sensitivity of the
MNY as compared to the NY. In our opinion, this higher sensitivity is justified and valid as
the patients with mechanical back pain were excluded by the new criteria and in the group of
14 patients in whom the diagnosis of definite AS could only be reached by application of the
MNY, the HLA-B27 prevalence was 71% which is comparable with the AS patients meeting
the NY criteria. Also, the mean duration of complaints was shorter, 3.8 years versus 6.2
years for the whole group of 151 patients. These results suggest that the additional patients
satisfying the MNY criteria are relatively early cases of AS.
Significant differences for the presence of the second and third MNY and the second
Rome were found when the prevalences of these criteria were related to the duration of the
disease (Table VI) and the same applies to radiological involvement of the lumbar spine
(Table VII). These findings suggest that these criteria are less useful for the diagnosis of early
disease, especially during the first five years of symptoms when the first MNY seems to be
more useful.
The use of tissue-typing is not included in any set of diagnostic criteria although there is
a high degree of association between HLA-B27 positivity and definite AS. Used in conjunc-
tion with the screening test alone the rate of false negative AS cases (18% in this series) and
false positives (22% in this series) is unacceptably high (Table III). Jajic (7) studied 652
patients with back pain of more than three months' duration but only 128 of the 276, who
were HLA-B27 positive, had definite AS. In the present study 51% of the 43 HLA-B27
negative patients with inflammatory back pain met the clinical and radiological criteria for
AS and would have been excluded by criteria which include HLA-B27 positivity. There were
no apparent differences between the HLA-B27 positive and negative groups, and tissue
typing should not therefore be included in diagnostic criteria because of its poor sensitivity
and specificity. However, there appears to be a group of patients with inflammatory back
pain without sacro-iliitis, but with a high prevalence of HLA-B27 (8). Tissue-typing will
therefore remain important for classifying these subgroups of spondylitic diseases and
possibly for defining the pathogenetic significance of HLA markers.
In conclusion, the clinical history screening test has proved valuable for the detection of
AS in patients referred to a rheumatology out-patient department with back pain. The value
of the test in general practice and in the open population has not yet been established. The
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newly described MNY applied to patients with inflammatory back pain, appear to be more
sensitive for detecting early cases of AS than the previous criteria and have comparable
specificity. The individual criteria relating to restriction of spinal movement and chest
expansion are apparently related to duration of disease and might therefore have additional
value over their use in diagnosis.
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